A smart watch for respiratory disease patients launched by Aseptika monitors the oxygen levels in patients’ blood.
Lab Corp has announced the availability of a reflex test to identify EV-D68.
Sapheneia Inc and Scannerside have launched a single-source solution for CMS lung screening.
RT takes a look at some of the current offerings in the simulation sector, which are helping to test equipment and train novice and veteran respiratory care practitioners and improve quality of care.
Thanks to a new partnership with Microsoft, Aerocrine is exploring possibilities for its FeNO diagnostic medical devices to venture into the world of telemedicine.
ResMed has launched its new AirCurve 10 series, which includes three bilevel devices for to treat sleep apnea, and an adaptive servo-ventilation device for patients with central sleep apnea or Cheyne-Stokes respiration.
PulmoFlow Inc’s Kitabis Pak, a co-packaging of generic tobramycin inhalation solution with a PARI LC PLUS Nebulizer, has been approved to treat cystic fibrosis.
A new study found that Anoro Ellipta ((umeclidinium /vilanterol) showed a statistically significant improvement in lung function compared with tiotropium for COPD patients.
IntelliQuit, the world’s first personal pocket size biosensor and ecosystem that biochemically measures tobacco consumption to help smokers quit, is now available on-line via Kickstarter.
Royal Philips and Radboud University Medical Center (Nijmegen, Netherlands) have launched a prototype monitoring device to support patients with COPD.